Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q90941054)
Watch
English
Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion
scientific article published on 14 August 2018
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
30107055
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30107055%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 April 2020
title
Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
30107055
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30107055%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 April 2020
main subject
malignant pleural effusion
1 reference
based on heuristic
inferred from title
adenocarcinoma
1 reference
based on heuristic
inferred from title
author
Shang-Gin Wu
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
30107055
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30107055%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 April 2020
Jin-Yuan Shih
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
30107055
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30107055%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 April 2020
author name string
Yi-Nan Liu
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
30107055
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30107055%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 April 2020
Chong-Jen Yu
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
30107055
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30107055%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 April 2020
James Chih-Hsin Yang
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
30107055
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30107055%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 April 2020
publication date
14 August 2018
1 reference
stated in
Europe PubMed Central
PubMed publication ID
30107055
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30107055%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 April 2020
published in
Genes, Chromosomes and Cancer
1 reference
stated in
Europe PubMed Central
PubMed publication ID
30107055
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30107055%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 April 2020
volume
57
1 reference
stated in
Europe PubMed Central
PubMed publication ID
30107055
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30107055%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 April 2020
issue
10
1 reference
stated in
Europe PubMed Central
PubMed publication ID
30107055
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30107055%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 April 2020
page(s)
513-521
1 reference
stated in
Europe PubMed Central
PubMed publication ID
30107055
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30107055%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 April 2020
cites work
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Crizotinib in ROS1-rearranged non-small-cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ceritinib in ALK-rearranged non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lung cancer in young patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lung cancer in patients under age 40.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cancer statistics, 2016
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lung cancer in individuals less than 50 years of age
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lung cancer in young adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Toxicity and response criteria of the Eastern Cooperative Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Menopause
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Discordant HER2 Exon 20 Mutation Status Determines a Differential Sensitivity to Afatinib.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival of lung adenocarcinoma patients with malignant pleural effusion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomas
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lung Adenocarcinoma From East Asian Never-Smokers Is a Disease Largely Defined by Targetable Oncogenic Mutant Kinases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexed
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anaplastic lymphoma kinase translocation: a predictive biomarker of pemetrexed in patients with non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ROS1 rearrangements define a unique molecular class of lung cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifying and targeting ROS1 gene fusions in non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinicopathologic analysis of ROS1-rearranged non-small-cell lung cancer and proposal of a diagnostic algorithm.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical cases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of crizotinib and pemetrexed-based chemotherapy in Chinese NSCLC patients with ROS1 rearrangement
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lung cancer: intragenic ERBB2 kinase mutations in tumours
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
KIF5B-RET fusions in lung adenocarcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High frequency of mutations of the PIK3CA gene in human cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PIK3CA mutation status in Japanese lung cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PIK3CA mutations and copy number gains in human lung cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non-Small-Cell Lung Cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: a prospective, single-institute study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analysis of receptor tyrosine kinase ROS1-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FGCC.22647
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/GCC.22647
1 reference
stated in
Europe PubMed Central
PubMed publication ID
30107055
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30107055%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 April 2020
PubMed publication ID
30107055
1 reference
stated in
Europe PubMed Central
PubMed publication ID
30107055
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30107055%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 April 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit